Nanchang

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Amyloidosis1 trial
• High blood pressure1 trial
• Myasthenia gravis1 trial

Phase

• Phase 32 trials

Status

• Recruiting3 trials

Lead sponsor

• Alnylam Pharmaceuticals2 trials
• Alexion Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT07052903· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  NCT04202341· Alexion Pharmaceuticals, Inc.· Source

  Contact: Alexion Pharmaceuticals, Inc. (Sponsor)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis1 recruiting
• High blood pressure1 recruiting
• Myasthenia gravis1 recruiting